知镜 Cognispect · 医学文献与研究工作台

Association between serum Total Antioxidant Status, Malondialdehyde and Coronary Artery Disease severity: A Cross-Sectional Study.

Van H, Dung NT, Huong BTT, Anh DT, Yen HH, Diep Anh NT.
La Clinica terapeutica · 2026-09-01 · PMID 42664132

文献摘要

Background Reduced Total Antioxidant Status (TAS) and elevated Malondialdehyde (MDA) reflect redox imbalance in coronary artery disease (CAD). Their inverse relationship may help assess cardiovascular risk and disease progression. Objectives To evaluate the association between serum TAS, MDA and the severity of coronary artery damage in CAD patients at Thai Nguyen National Hospital. Results Serum TAS showed no significant differences by number of stenotic vessels or lesion sites (p > 0.05). TAS was slightly higher in single-vessel disease (1.15 ± 0.38 mmol/L) than in two-vessel (1.08 ± 0.19) and ≥3-vessel groups (1.09 ± 0.18), without statistical significance (p = 0.721). A significant difference was observed only in the right coronary artery (RCA), where TAS peaked in moderate stenosis and decreased in severe stenosis (p = 0.039). In contrast, MDA increased significantly with disease extent: 255.25 ± 48.43 nmol/mL (1-vessel), 281.30 ± 62.56 (2-vessel), and 317.06 ± 54.53 (≥3-vessel) (p = 0.001). MDA also rose markedly with SYNTAX score (low: 239.98 ± 40.96; medium: 271.49 ± 46.53; high: 392.62 ± 90.85 nmol/mL; p Conclusions TAS is not associated with CAD severity, whereas MDA strongly correlates with disease extent and complexity. MDA may serve as a useful biomarker for oxidative stress and risk stratification in CAD.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。